Table 1 Baseline characteristic of patients with and without multidisciplinary pre-dialysis care
Multidisciplinary care | |||||
|---|---|---|---|---|---|
No | Yes | ||||
N = 126 | N = 546 | ||||
Variables | n | % | n | % | p-value |
Gender | 0.65 | ||||
Female | 63 | 50% | 288 | 53% | |
Male | 63 | 50% | 258 | 47% | |
Age, years | 0.005 | ||||
18–30 | 9 | 7% | 15 | 3% | |
31–50 | 40 | 32% | 166 | 30% | |
50–70 | 66 | 52% | 258 | 47% | |
> 71 | 11 | 9% | 107 | 20% | |
mean, (SD) | 52.2 | (13.7) | 56.5 | (14.4) | 0.002 |
Smoking | 0.09 | ||||
Current | 14 | 13% | 47 | 9% | |
Ever | 8 | 7% | 22 | 4% | |
Alcohol drinking | 0.26 | ||||
Current | 2 | 2% | 8 | 1% | |
Ever | 7 | 7% | 18 | 3% | |
Comorbidities | |||||
Diabetes | 61 | 48% | 236 | 43% | 0.34 |
Hypertension | 93 | 74% | 415 | 76% | 0.39 |
Cardiovascular disease | 30 | 24% | 139 | 25% | 0.79 |
Liver cirrhosis | 1 | 1% | 18 | 3% | 0.22 |
Gout | 14 | 11% | 31 | 6% | 0.05 |
Cancer | 2 | 2% | 16 | 3% | 0.59 |
TB | 0 | 0% | 1 | 0.2% | - |
HBV | 20 | 16% | 59 | 11% | 0.15 |
HCV | 9 | 7.1% | 39 | 7.1% | 1.00 |
Icodextrin use | 54 | 43% | 190 | 35% | 0.11 |
APD use | 28 | 22% | 219 | 40% | < 0.001 |
PET | 0.72 | ||||
Low/low average | 44 | 35% | 183 | 34% | |
High/high average | 79 | 63% | 362 | 66% | |
Systolic blood pressure (mmHg) | 0.76 | ||||
mean, (SD) | 142.7 | (24.4) | 143.4 | (21.8) | |
Diastolic blood pressure (mmHg) | 1.00 | ||||
mean, (SD) | 81.3 | (13.7) | 81.3 | (14.4) | |
Kt/V | 0.32 | ||||
mean, (SD) | 1.93 | (0.38) | 1.97 | (0.43) | |
Renal, Kt/V | < 0.001 | ||||
mean, (SD) | 0.47 | (0.36) | 0.66 | (0.43) | |
Peritoneal, Kt/V | < 0.001 | ||||
mean, (SD) | 1.46 | (0.37) | 1.31 | (0.36) | |
Albumin (g/dL) | 0.42 | ||||
mean, (SD) | 3.53 | (0.47) | 3.57 | (0.51) | |
nPNA (g/kg/day) | 0.50 | ||||
mean, (SD) | 1.04 | (0.24) | 1.05 | (0.26) | |
P (mg/dL) | 0.08 | ||||
< 3.5 | 8 | 6% | 30 | 5% | |
3.5–5.5 | 58 | 46% | 230 | 42% | |
> 5.5 | 60 | 48% | 286 | 52% | |
mean, (SD) | 5.45 | (1.52) | 5.73 | (1.62) | 0.07 |
Hb (g/dL) | 0.75 | ||||
mean, (SD) | 9.98 | (1.37) | 9.93 | (1.44) | |
HbA1c | 0.64 | ||||
mean, (SD) | 6.75 | (1.34) | 6.83 | (1.47) | |
Years of dialysis initiation | 0.04 | ||||
2007–2010 | 39 | 31% | 137 | 25% | |
2011–2014 | 62 | 49% | 240 | 44% | |
2015–2017 | 25 | 20% | 169 | 31% | |
Break in period, days | |||||
mean, (SD) | 20.9 | (77.7) | 25.9 | (65.3) | 0.51 |
Etiology of ESKD | 0.46 | ||||
Diabetes | 55 | 44% | 215 | 39% | |
Chronic glomerulonephritis | 45 | 36% | 202 | 37% | |
Hypertension | 12 | 10% | 66 | 12% | |
Chronic tubulointerstital disease | 11 | 9% | 32 | 6% | |
Adult polycystic kidney disease | 1 | 1% | 14 | 3% | |
Obstructive uropathy | 0 | 0% | 8 | 1% | |
Others | 2 | 2% | 9 | 2% | |